Employee Benefits News examines legal developments that impact the employee benefits and executive compensation employers provide, including federal and state legislation, rules from federal...
GreatBanc Trust Co., one of the largest trust companies in the U.S., is accused of breaching its fiduciary duties by authorizing the sale of Chemonics International Inc. stock to the company’s employee stock ownership plan for more than fair market value ( McMaken v. GreatBanc Tr. Co. , N.D. Ill., No. 1:17-cv-04983, complaint filed 7/5/17 ).
GreatBanc, as the ESOP trustee, allegedly caused the plan to pay $216 million for Chemonics stock—a transaction financed by Chemonics shareholders, who were also the sellers with a note to be repaid over a 20-year period—according to a lawsuit filed July 5 in the U.S. District Court for the Northern District of Illinois. To authorize the transaction, GreatBanc allegedly relied on unrealistic growth projections, unreliable or out-of-date financial documents, improper discount rates, and inappropriate comparable companies, the lawsuit said.
The ESOP transaction, which took place in 2011, allowed the company shareholders to unload their interests in Chemonics at an inflated price and saddle participants with millions of dollars of debt to finance the transaction, the lawsuit said.
The ESOP paid a control premium for Chemonics even though it didn’t obtain control over the company after its purchase, as the shareholders continued to control the board of directors, the lawsuit said. The plan didn’t receive a discount for lack of control, according to the lawsuit.
GreatBanc’s handling of ESOP transactions had landed it in hot water several times. Last year, a federal appeals court reversed a district court decision in GreatBanc’s favor, holding that participants in the Personal-Touch Home Care Inc.'s ESOP made sufficient allegations of fiduciary breach against the trustee to survive dismissal. A Department of Labor lawsuit against GreatBanc settled for more than $5 million in 2014.
The new lawsuit was filed by Michael V. McMaken, Chemonics’ former director of safety and security. He seeks class treatment for 2,454 plan participants.
GreatBanc didn’t immediately respond to Bloomberg BNA’s request for comments.
Bailey & Glasser LLP represents the proposed class.
To contact the reporter on this story: Carmen Castro-Pagan in Washington at email@example.com
To contact the editor responsible for this story: Jo-el J. Meyer at firstname.lastname@example.org
Copyright © 2017 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)